Naodong Jiguang (06681.HK) +0.120 (+2.864%) Short selling $262.96K; Ratio 0.131% announced that it has recently officially become a strategic cooperation partner of the Beijing Frontier Brain-Computer Interface Research Institute. Its subsidiary, Zhejiang Naodong Jiguang Medical Technology, signed a strategic cooperation agreement on-site with the Beijing Frontier Brain-Computer Interface Research Institute on March 27.Under the agreement, both parties will jointly advance the research and development as well as clinical validation of key products in the brain-computer interface field. The Group will collaborate with the institute and other strategic partners to promote joint R&D in key areas including multimodal neurological disease databases, large-scale neuroelectrophysiology models, and closed-loop neuromodulation brain-computer interface products, aiming to build an innovative ecosystem integrating medicine and engineering and fostering industry-academia collaboration. (ca/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)Related News Brainhole Technology (06681.HK) Annual Loss Widens to RMB315 Million
AASTOCKS Financial News